Patents by Inventor Ron Cohen
Ron Cohen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240127800Abstract: A system including an interaction processing component is deployed to automatically validate information exchanged during an interaction.Type: ApplicationFiled: October 17, 2022Publication date: April 18, 2024Inventors: Ron Peretz Epstein Koch, Ian Beaver, Dvir Cohen
-
Publication number: 20240126991Abstract: An automated interaction processing system is deployed to automatically process an interaction transcription or content to generate response data in a manner that does not require intensive human manual effort.Type: ApplicationFiled: October 12, 2022Publication date: April 18, 2024Inventors: Ron Peretz Epstein Koch, Avidor Tenenboim, Dvir Cohen, Eran Sela
-
Patent number: 11962483Abstract: Systems and methods for application performance management across one or more networks are disclosed. A system includes a plurality of geographically distributed computing devices executing one or more applications. A plurality of collectors are distributed across the one or more networks, each collector being positioned proximate a respective computing device. The collectors may sample, by each of the plurality of collectors, a plurality of trace events received from the applications executing on the computing devices proximate the collector. The collectors may retain in memory sampled trace events that meet a configurable attribute. The collectors may use probabilistic sets and tail-based sampling to determine root events and policies for identifying relevant traces. Benefits can be achieved in bandwidth savings, network cost and cyber security.Type: GrantFiled: September 7, 2022Date of Patent: April 16, 2024Assignee: Elasticsearch B.V.Inventors: Andrew Wilkins, Ron Cohen
-
Patent number: 11955732Abstract: Millimeter wave (mmWave) technology, apparatuses, and methods that relate to transceivers, receivers, and antenna structures for wireless communications are described. The various aspects include co-located millimeter wave (mmWave) and near-field communication (NFC) antennas, scalable phased array radio transceiver architecture (SPARTA), phased array distributed communication system with MIMO support and phase noise synchronization over a single coax cable, communicating RF signals over cable (RFoC) in a distributed phased array communication system, clock noise leakage reduction, IF-to-RF companion chip for backwards and forwards compatibility and modularity, on-package matching networks, 5G scalable receiver (Rx) architecture, among others.Type: GrantFiled: December 27, 2022Date of Patent: April 9, 2024Assignee: Intel CorporationInventors: Erkan Alpman, Arnaud Lucres Amadjikpe, Omer Asaf, Kameran Azadet, Rotem Banin, Miroslav Baryakh, Anat Bazov, Stefano Brenna, Bryan K. Casper, Anandaroop Chakrabarti, Gregory Chance, Debabani Choudhury, Emanuel Cohen, Claudio Da Silva, Sidharth Dalmia, Saeid Daneshgar Asl, Kaushik Dasgupta, Kunal Datta, Brandon Davis, Ofir Degani, Amr M. Fahim, Amit Freiman, Michael Genossar, Eran Gerson, Eyal Goldberger, Eshel Gordon, Meir Gordon, Josef Hagn, Shinwon Kang, Te Yu Kao, Noam Kogan, Mikko S. Komulainen, Igal Yehuda Kushnir, Saku Lahti, Mikko M. Lampinen, Naftali Landsberg, Wook Bong Lee, Run Levinger, Albert Molina, Resti Montoya Moreno, Tawfiq Musah, Nathan G. Narevsky, Hosein Nikopour, Oner Orhan, Georgios Palaskas, Stefano Pellerano, Ron Pongratz, Ashoke Ravi, Shmuel Ravid, Peter Andrew Sagazio, Eren Sasoglu, Lior Shakedd, Gadi Shor, Baljit Singh, Menashe Soffer, Ra'anan Sover, Shilpa Talwar, Nebil Tanzi, Moshe Teplitsky, Chintan S. Thakkar, Jayprakash Thakur, Avi Tsarfati, Yossi Tsfati, Marian Verhelst, Nir Weisman, Shuhei Yamada, Ana M. Yepes, Duncan Kitchin
-
Publication number: 20240077943Abstract: A display system can include a head-mounted display configured to project light to an eye of a user to display virtual image content at different amounts of divergence and collimation. The display system can include an inward-facing imaging system possibly comprising a plurality of cameras that image the user's eye and glints for thereon and processing electronics that are in communication with the inward-facing imaging system and that are configured to obtain an estimate of a center of rotation of the user's eye using cornea data derived from the glint images. The display system may render virtual image content with a render camera positioned at the determined position of the center of rotation of said eye.Type: ApplicationFiled: November 7, 2023Publication date: March 7, 2024Inventors: David Cohen, Elad Joseph, Ron Nisim Ferens, Eyal Preter, Eitan Shmuel Bar-On, Giora Yahav
-
Publication number: 20240041850Abstract: A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at about 12 hours and the use of the composition to treat various neurological diseases, including multiple sclerosis. A method of selecting individuals based on responsiveness to a treatment, including, for example, identifying individuals who responded to treatment with a sustained release fampridine composition.Type: ApplicationFiled: October 9, 2023Publication date: February 8, 2024Applicant: Acorda Therapeutics, Inc.Inventors: Andrew R. Blight, Ron Cohen
-
Publication number: 20230390261Abstract: A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at least 12 hours, preferably 24 hours or more and the use of the composition to treat various neurological diseases.Type: ApplicationFiled: August 23, 2023Publication date: December 7, 2023Applicant: Acorda Therapeutics, Inc.Inventors: Andrew R. Blight, Ron Cohen
-
Publication number: 20230300068Abstract: A distributed routing system is provided for use in a communication network, wherein the distributed routing system includes at least one cluster comprising a plurality of cluster elements and characterized in that the cluster elements that are used for forwarding communication traffic from among the plurality of cluster elements are synchronized there-between to a single clock and then synchronized to an external communication element, such as a client clock. Optionally, all the cluster elements that are used for forward communication traffic, are configured to implement IEEE 1588 standard and/or Synchronous Ethernet (Sync-E).Type: ApplicationFiled: June 29, 2021Publication date: September 21, 2023Inventors: Eliezer KOSHAROVSKY, Amir KRAYDEN, Evgeny SANDLER, Ron COHEN
-
Publication number: 20230300071Abstract: A distributed routing system is provided for use in a communication network. The distributed routing system comprises a plurality of forwarding modules and a plurality of fabric modules. At least one counter located at at least one respective fabric module is configured to receive data relating to the number of packets being forwarded via physical and/or logical interfaces associated with at least two of the plurality of forwarding modules.Type: ApplicationFiled: June 29, 2021Publication date: September 21, 2023Inventors: Ron COHEN, Evgeny SANDLER, Amir KRAYDEN, Alexander ZILBERMAN
-
Publication number: 20230263105Abstract: A plant root management and protection system configured for embedding within a dug pit, the system comprising: a sidewall peripherally defining a receiving internal cavity and having (i) a top opening dimensioned to receive a root ball of a plant therethrough, and (ii) a bottom opening defined by a peripheral edge of the sidewall; and at least one root-guiding extension extending outwardly from the sidewall and perpendicularly to a longitudinal axis of the sidewall, wherein each of the at least one root-guiding extensions defines an open-ended hollow passageway in communication with the cavity; wherein, when embedded a dug pit, the longitudinal axis of the sidewall is upright and the top opening does not extend above surface level, and wherein at least a vertical portion of the sidewall ending with the peripheral edge is configured for entrenching in a bottom surface of the pit.Type: ApplicationFiled: June 24, 2021Publication date: August 24, 2023Inventors: Shachar ZUR, Ron COHEN, Jacov EILON, Yehonatan ANTEBI, Shlomo SHALEV
-
Publication number: 20230133230Abstract: A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at least 12 hours, preferably 24 hours or more and the use of the composition to treat various neurological diseases.Type: ApplicationFiled: December 29, 2022Publication date: May 4, 2023Applicant: Acorda Therapeutics, Inc.Inventors: Andrew R. Blight, Ron Cohen
-
Publication number: 20230078122Abstract: Systems and methods for application performance management across one or more networks are disclosed. A system includes a plurality of geographically distributed computing devices executing one or more applications. A plurality of collectors are distributed across the one or more networks, each collector being positioned proximate a respective computing device. The collectors may sample, by each of the plurality of collectors, a plurality of trace events received from the applications executing on the computing devices proximate the collector. The collectors may retain in memory sampled trace events that meet a configurable attribute. The collectors may use probabilistic sets and tail-based sampling to determine root events and policies for identifying relevant traces. Benefits can be achieved in bandwidth savings, network cost and cyber security.Type: ApplicationFiled: September 7, 2022Publication date: March 16, 2023Applicant: Elasticsearch B.V.Inventors: Andrew Wilkins, Ron Cohen
-
Patent number: 11526413Abstract: Methods and systems for providing distributed tracing for application performance monitoring utilizing a distributed search engine in a microservices architecture. An example method comprises providing a user interface (UI) including a distributed trace indicating in real time the services invoked to serve an incoming HTTP request including dependent services, the UI further including, in a single view, associated execution times for the services and dependent services shown as a timeline waterfall. The distributed trace automatically propagates a trace ID to link services end-to-end in real time until a response to the request is served. Spans associated with the services and dependent can be compressed using various techniques provided for herein.Type: GrantFiled: January 24, 2022Date of Patent: December 13, 2022Assignee: Elasticsearch B.V.Inventors: Felix Barnsteiner, Sergey Kleyman, Alexander Wert, Rasmus Makwarth, Ron Cohen
-
Publication number: 20220296577Abstract: A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at least 12 hours, preferably 24 hours or more and the use of the composition to treat various neurological diseases.Type: ApplicationFiled: June 2, 2022Publication date: September 22, 2022Applicant: Acorda Therapeutics, Inc.Inventors: Andrew R. Blight, Ron Cohen
-
Publication number: 20220171689Abstract: Methods and systems for providing distributed tracing for application performance monitoring utilizing a distributed search engine in a microservices architecture. An example method comprises providing a user interface (UI) including a distributed trace indicating in real time the services invoked to serve an incoming HTTP request including dependent services, the UI further including, in a single view, associated execution times for the services and dependent services shown as a timeline waterfall. The distributed trace automatically propagates a trace ID to link services end-to-end in real time until a response to the request is served. The single view also provides graphs of response time information and the distribution of response times for the services dependent services. In response to selection of a particular element of the distribution, the UI provides respective timing details.Type: ApplicationFiled: January 24, 2022Publication date: June 2, 2022Inventors: Felix Barnsteiner, Sergey Kleyman, Alexander Wert, Rasmus Makwarth, Ron Cohen
-
Patent number: 11252876Abstract: A system having an elongated body defining a hollow passageway therethrough, which includes as a first opening disposed about a longitudinal upper half of the elongated body, and at least two second openings disposed about longitudinal side zones of the elongated body, wherein each of the at least two second opening has an area of between 80 and 700 cm2.Type: GrantFiled: September 4, 2018Date of Patent: February 22, 2022Assignee: TREE-TUBE LTD.Inventors: Ron Cohen, Yehonatan Antebi, Jacob Eilon, Shachar Zur
-
Publication number: 20220040161Abstract: A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at least 12 hours, preferably 24 hours or more and the use of the composition to treat various neurological diseases.Type: ApplicationFiled: October 26, 2021Publication date: February 10, 2022Applicant: Acorda Therapeutics, Inc.Inventors: Andrew R. Blight, Ron Cohen
-
Patent number: 11240126Abstract: Methods and systems for providing distributed tracing for application performance monitoring utilizing a distributed search engine in a microservices architecture. An example method comprises providing a user interface (UI) including a distributed trace indicating in real time the services invoked to serve an incoming HTTP request, the UI further including, in a single view, associated execution times for the services shown as a timeline waterfall. The distributed trace automatically propagates a trace ID to link services end-to-end in real time until a response to the request is served. The single view also provides graphs of response time information and the distribution of response times for the services. In response to selection of a particular element of the distribution, the UI provides respective timing details. The graphs and data shown on the single view can be filtered based on metadata input into a search field of the single view.Type: GrantFiled: April 11, 2019Date of Patent: February 1, 2022Assignee: Elasticsearch B.V.Inventors: Rasmus Makwarth, Ron Cohen
-
Publication number: 20210251974Abstract: A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at about 12 hours and the use of the composition to treat various neurological diseases, including multiple sclerosis. A method of selecting individuals based on responsiveness to a treatment, including, for example, identifying individuals who responded to treatment with a sustained release fampridine composition.Type: ApplicationFiled: May 4, 2021Publication date: August 19, 2021Applicant: Acorda Therapeutics, Inc.Inventors: Andrew R. Blight, Ron Cohen
-
Publication number: 20210205282Abstract: A pharmaceutical composition which comprises a therapeutically effective amount of a aminopyridine dispersed in a release matrix, including, for example, a composition that can be formulated into a stable, sustained-release oral dosage formulation, such as a tablet which provides, upon administration to a patient, a therapeutically effective plasma level of the aminopyridine for a period of at least 12 hours, preferably 24 hours or more and the use of the composition to treat various neurological diseases.Type: ApplicationFiled: March 16, 2021Publication date: July 8, 2021Applicant: Acorda Therapeutics, Inc.Inventors: Andrew R. Blight, Ron Cohen
